| 前收市價 | 17.65 |
| 開市 | 17.73 |
| 買盤 | 17.78 x 200 |
| 賣出價 | 17.87 x 200 |
| 今日波幅 | 17.54 - 18.15 |
| 52 週波幅 | 6.08 - 45.07 |
| 成交量 | |
| 平均成交量 | 745,804 |
| 市值 | 697.308M |
| Beta 值 (5 年，每月) | 1.48 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.44 |
| 業績公佈日 | 2024年4月30日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 20.17 |
ZacksAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
Silk Road Medical (SILK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
ZacksSilk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
